Error: Twitter did not respond. Please wait a few minutes and refresh this page.
Tag Archives: MDS
We all like happy endings and this is the best kind! Just last week, rigosertib, a myelodysplastic syndrome (MDS) drug with tremendous potential, received sizable funding – the kind that will get it across and beyond the finish line. It’s a great story, … Continue reading
Today there are just a handful of treatments for patients with myelodysplastic syndrome (MDS), a condition that involves ineffective blood cell production. Patients often develop severe anemias and require frequent blood transfusions. In the worst case scenario, MDS can evolve into … Continue reading